Source - RNS
RNS Number : 3342K
JPMorgan Securities Plc
09 April 2018
 

AMENDMENT

INCREASED EQUITY SALES BY 2,600 TO 30,300

ADDED EQUITY SWAP PURCHASES OF 7,100

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Takeda Pharmaceutical Company Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Joint Financial Adviser to Takeda Pharmaceutical Company Limited

(d) Date dealing undertaken:

28 March 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

     If it is a cash offer or possible cash offer, state "N/A"

Yes, Shire plc

 

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

(JPY)

Lowest price per unit paid/received

(JPY)

Common Stock

Purchases

 

Sales

30,700

 

30,300

5,532.4425

 

5,532.4425

5479.4314

 

5479.4314

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(JPY)

Common Stock

Equity Swaps

 

Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short

1,300

300

1,100

10,700

2,600

100

3,100

1,600

200

1,100

700

300

14,200

1,500

4,100

100

9,100

7,100

400

2,500

 

1,300

11,400

1,900

100

3,100

4,100

900

1,100

1,100

200

1,900

5,300

4,100

100

7,500

7,600

400

400

2,500

5478.4521

5488.0000

5489.0000

5489.0748

5490.2308

5492.0000

5493.2142

5496.8750

5503.0000

5504.9591

5506.5714

5509.3333

5509.3927

5510.8000

5511.3120

5523.0000

5527.7949

5532.0000

5532.4425

5538.4461

 

5479.0000

5490.4511

5491.0526

5492.4394

5493.5161

5500.3513

5504.4400

5504.7273

5504.9591

5508.0000

5509.7895

5510.8835

5511.7805

5514.0000

5527.2667

5532.0000

5532.4425

5532.4979

5539.0000

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

 

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 









 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 





 

 

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)


 

 



 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

09 April 2018

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERUKUNRWWASRAR